Hans Verbaan
- Epidemiology top 2%
- Hepatology top 0.5%
- Genetics top 2%
- Surgery top 10%
- Rheumatology top 5%
- Co-authors
- Ingalill Friis–LibyM. VilienErik HertervigPer KarlénAnders MagnusonPer M. HellströmChrister GrännöLars Blomquist
- Topics
- Liver Disease Diagnosis and Treatment (27 papers)Hepatitis C virus research (27 papers)Hepatitis B Virus Studies (16 papers)
- Cited by
- HepatologyEpidemiologyGenetics
- Journals
- GastroenterologyPLoS ONEHepatology
In The Last Decade
Hans Verbaan
43 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Epidemiology 1.6k
- Hepatology 1.0k
- Genetics 905
- Surgery 400
- Rheumatology 185
Countries citing papers authored by Hans Verbaan
This map shows the geographic impact of Hans Verbaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Verbaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Verbaan more than expected).
Fields of papers citing papers by Hans Verbaan
This network shows the impact of papers produced by Hans Verbaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Verbaan. The network helps show where Hans Verbaan may publish in the future.
Co-authorship network of co-authors of Hans Verbaan
This figure shows the co-authorship network connecting the top 25 collaborators of Hans Verbaan. A scholar is included among the top collaborators of Hans Verbaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Verbaan. Hans Verbaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 40 | |
| 3 | 3 | |
| 4 | 22 | |
| 5 | IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection | 6 |
| 6 | 133 | |
| 7 | Il28B Genetic Variation And Treatment Response In Patients With Hcv Genotype 3 Infection | 4 |
| 8 | 7 | |
| 9 | 52 | |
| 10 | 41 | |
| 11 | IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS | 2 |
| 12 | Colectomy after rescue therapy for intravenous-steroid resistant acute ulcerative colitis : a 3-year follow-up study of the Swedish-Danish infliximab/placebo trial | 4 |
| 13 | 4 | |
| 14 | 6 | |
| 15 | A 2-year follow-up of the swedish-danish Infliximab/Placebo trial in steroid resistant acute ulcerative colitis | 14 |
| 16 | Capsule endoscopic diagnosis of small bowel Crohn's disease: a prospective, comparative study of capsule enteroscopy, barium enterography, push enteroscopy and ileo-colonoscopy | 4 |
| 17 | 23 | |
| 18 | 30 | |
| 19 | 14 | |
| 20 | 46 |
About Hans Verbaan
Hans Verbaan is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (27 papers), Hepatitis C virus research (27 papers) and Hepatitis B Virus Studies (16 papers). The work is most often cited by research in Hepatology (1.0k citations), Epidemiology (1.6k citations) and Genetics (905 citations). Hans Verbaan has collaborated with scholars based in Sweden, Denmark and Norway. Frequent co-authors include Ingalill Friis–Liby, M. Vilien, Erik Hertervig, Per Karlén, Anders Magnuson, Per M. Hellström, Christer Grännö, Lars Blomquist, Magnus Ström and Gunnar Järnerot. Their work appears in journals such as Gastroenterology, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.